Angiotensin Receptor Blockers Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: Cansartan

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

Sherief Abd-Elsalam1
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1

Indications

Aortic Stenosis1
Aortic Valve Stenosis1
Heart Disease1
Arthritis1
Rheumatoid Arthritis1

Other2 trials

Angiotensin Receptor Blockers in Aortic Stenosis

Phase 4

Statins and ARBs on Rheumatoid Activity

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.